Cargando…
Outcome of transcutaneous retrobulbar injection of liposomal amphotericin B in post-COVID-19 rhino-orbito-cerebral mucormycosis: Our experience
PURPOSE: To assess the outcome and response of transcutaneous retrobulbar injection of amphotericin B (TRAMB) in post-coronavirus disease of 2019 (COVID-19) rhino-orbito-cerebral mucormycosis (ROCM) and to establish a scoring system in guiding treatment modalities. METHODS: An interventional, prospe...
Autores principales: | Ramamurthy, Lakshmi B, Bhandari, Ridhi, Kanakpur, Savitha, Thejaswini, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114606/ https://www.ncbi.nlm.nih.gov/pubmed/35225564 http://dx.doi.org/10.4103/ijo.IJO_2356_21 |
Ejemplares similares
-
Retrobulbar injection of amphotericin B using intravenous cannula for post-COVID-19 rhino-orbital mucormycosis
por: Murthy, Ramesh, et al.
Publicado: (2022) -
Retrospective analysis of the role of retrobulbar amphotericin-B injection in the management of COVID-19 associated rhino-orbito-cerebral-mucormycosis
por: Yadav, Rekha, et al.
Publicado: (2022) -
Transcutaneous retrobulbar amphotericin-B (TRAMB) injection in orbital mucormycosis
por: Singh, Prabhakar, et al.
Publicado: (2022) -
Rhino-orbito-cerebral mucormycosis
por: Raymundo, Igor Teixeira, et al.
Publicado: (2015) -
Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19
por: Shakrawal, Jyoti, et al.
Publicado: (2022)